> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Avinger Chronic Total Occlusion Device Cleared
- URL: https://www.fdaweb.com/avinger-chronic-total-occlusion-device-cleared/
- Published: 2020-09-11T12:00:00.000Z
- Updated: 2026-09-14T16:28:26.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5147638

FDA has cleared an Avinger 510(k) for its TigerEye image-guided chronic total occlusion (CTO) crossing system. The device provides real-time imaging from inside the vessel during a CTO-crossing procedure, the company says. It is designed with an upgraded image capture that provides high definition, real-time intravascular imaging. Additionally, Tigereye features a distal tip configuration with rotational speeds up to 1,000 RPM designed to penetrate challenging lesions, and the catheter has a working length of 140 cm and 5 French sheath compatibility for treatment of lesions in the peripheral vessels both above and below the knee, the company says.